FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Respecting EVS Workers: 19 Minutes Is Not Enough

The infection control problem is time, and it's up to facility managers, EVS directors and infection preventionists to address the problem.

Where are the Greenhouse Gas Emissions Hotspots in Healthcare?

First-year findings from Boston Medical Center show medical waste generates a disproportionate amount of healthcare emissions.

Caravel Autism Health Opens Clinic in Lake Zurich, Illinois

The clinic features colorful, sensory-friendly spaces where children work one-on-one with therapists.

The Future of Healthcare Facility Construction Projects

Brian Cowperthwaite highlights the invisible work that impacts everyone who walks through a healthcare facility.

Ground Broken on Jupiter Medical Center's Second Hospital

The 53,000-square-foot hospital will include 29 inpatient beds, four operating rooms, 24-hour emergency services, a diagnostic laboratory and imaging services.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.